[September 2022]
Paris, France – Plantibodies is proud to announce that it has been awarded the Hi France label in September 2022, joining a select group of French startups recognized for their potential to deliver high-impact innovation and strong economic development.
The Hi France label is granted by the French Association of Investors for Growth (AFIC, now France Invest) and Bpifrance Excellence, in partnership with regions and innovation clusters across France. It highlights companies that combine a solid business model with breakthrough innovation, strong growth potential, and the capacity to contribute to national and European technological sovereignty.
By receiving this label, Plantibodies is recognized as a deeptech company with the ability to transform healthcare through its proprietary biologics plant based bioproduction platform, enabling safer, more effective, and more sustainable treatments for inflammations, cancers and infections.
“This label is both a recognition of the work accomplished so far and a strong signal of confidence in our potential,” said Pierre Bauër, CEO and co-founder of Plantibodies. “It reinforces our credibility with investors, partners, and institutions as we continue scaling our innovation.”
With the Hi France label, Plantibodies gains enhanced visibility among French and European investors, access to networking opportunities with fellow laureates, and greater support for its fundraising and partnership activities.